Abstract
Tissue accumulation of L-2-hydroxyglutaric acid (L-2-HG) is the biochemical hallmark of L-2-hydroxyglutaric aciduria (L-2-HGA), a rare neurometabolic inherited disease characterized by neurological symptoms and brain white matter abnormalities whose pathogenesis is not yet well established. L-2-HG was intracerebrally administered to rat pups at postnatal day 1 (P1) to induce a rise of L-2-HG levels in the central nervous system (CNS). Thereafter, we investigated whether L-2-HG in vivo administration could disturb redox homeostasis and induce brain histopathological alterations in the cerebral cortex and striatum of neonatal rats. L-2-HG markedly induced the generation of reactive oxygen species (increase of 2′,7′-dichloroflurescein-DCFH-oxidation), lipid peroxidation (increase of malondialdehyde concentrations), and protein oxidation (increase of carbonyl formation and decrease of sulfhydryl content), besides decreasing the antioxidant defenses (reduced glutathione-GSH) and sulfhydryl content in the cerebral cortex. Alterations of the activities of various antioxidant enzymes were also observed in the cerebral cortex and striatum following L-2-HG administration. Furthermore, L-2-HG-induced lipid peroxidation and GSH decrease in the cerebral cortex were prevented by the antioxidant melatonin and by the classical antagonist of NMDA glutamate receptor MK-801, suggesting the involvement of reactive species and of overstimulation of NMDA receptor in these effects. Finally, L-2-HG provoked significant vacuolation and edema particularly in the cerebral cortex with less intense alterations in the striatum that were possibly associated with the unbalanced redox homeostasis caused by this metabolite. Taken together, it is presumed that these pathomechanisms may underlie the neurological symptoms and brain abnormalities observed in the affected patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126. https://doi.org/10.1016/S0076-6879(84)05016-3
Aghili M, Zahedi F, Rafiee E (2009) Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review. J Neuro-Oncol 91(2):233–236. https://doi.org/10.1007/s11060-008-9706-2
Aksenov MY, Markesbery WR (2001) Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer’s disease. Neurosci Lett 302(2-3):141–145. https://doi.org/10.1016/S0304-3940(01)01636-6
Anghileri E, Bertolino N, Salsano E, Antelmi L, Carpinelli P, Castellotti B, Zucca I, Gellera C, Bisogno R, Caccia C, Cuccarini V (2016) In-vivo brain H1-MR-spectroscopy identification and quantification of 2-hydroxyglutarate in L-2-Hydroxyglutaric aciduria. Brain Res 1648(Pt A):506–511. https://doi.org/10.1016/j.brainres.2016.08.013
Anisimov VN, Popovich IG, Zabezhinski MA, Anisimov SV, Vesnushkin GM, Vinogradova IA (2006) Melatonin as antioxidant, geroprotector and anticarcinogen. Biochim Biophys Acta 1757(5-6):573–589. https://doi.org/10.1016/j.bbabio.2006.03.012
Balaji P, Viswanathan V, Chellathurai A, Panigrahi D (2014) An interesting case of metabolic dystonia: L-2 hydroxyglutaric aciduria. Ann Indian Acad Neurol 17(1):97–99. https://doi.org/10.4103/0972-2327.128565
Barbot C, Fineza I, Diogo L, Maria M, Melo J, Guimarães A, Melo Pires M, Luis Cardoso M, Vila rinho L (1997) L-2-Hydroxyglutaric aciduria: clinical, biochemical and magnetic resonance imaging in six Portuguese pediatric patients. Brain Dev 19(4):268–273. https://doi.org/10.1016/S0387-7604(97)00574-3
Barth PG, Hoffmann GF, Jaeken J, RJA W, Duran M, Jansen GA, Jakobs C, Lehnert W, Hanefeld F, Valk J, RBH S, Trefz FK, Hartung HP, Chamoles NA, Sfaello Z, Caruso U (1993) L-2-hydroxyglutaric acidaemia: clinical and biochemical findings in 12 patients and preliminary report on L-2-hydroxyacid dehydrogenase. J Inherit Metab Dis 16(4):753–761. https://doi.org/10.1007/BF00711907
Browne RW, Armstrong D (1998) Reduced glutathione and glutathione disulfide. Methods Mol Biol 108:347–352. https://doi.org/10.1385/0-89603-472-0:347
Carlberg I, Mannervik B (1985) Glutathione reductase. Methods Enzymol 113:484–490. https://doi.org/10.1016/S0076-6879(85)13062-4
Circu ML, Aw TY (2010) Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48(6):749–762. https://doi.org/10.1016/j.freeradbiomed.2009.12.022
Cubells JF, Rayport S, Rajendran G, Sulzer D (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J Neurosci 14(4):2260–2271
da Rosa MS, João Ribeiro CA, Seminotti B, Teixeira Ribeiro R, Umpierrez Amaral A, de Moura Coelho D, de Oliveira FH, Leipnitz G, Wajner M (2015) In vivo intracerebral administration of L-2-hydroxyglutaric acid provokes oxidative stress and histopathological alterations in striatum and cerebellum of adolescent rats. Free Radic Biol Med 83:201–213. https://doi.org/10.1016/j.freeradbiomed.2015.02.008
da Silva CG, ARF B, Schuck PF, Leipnitz G, CAJ R, CMD W, ATS W, Wajner M (2003) L-2-hydroxyglutaric acid inhibits mitochondrial creatine kinase activity from cerebellum of developing rats. Int J Dev Neurosci 21(4):217–224. https://doi.org/10.1016/S0736-5748(03)00035-2
Fourati H, Ellouze E, Ahmadi M, Chaari D, Kamoun F, Hsairi I, Triki C, Mnif Z (2016) MRI features in 17 patients with l2 hydroxyglutaric aciduria. Eur J Radiol Open 3:245–250. https://doi.org/10.1016/j.ejro.2016.09.001
Grings M, Moura AP, Parmeggiani B, Pletsch JT, Cardoso GMF, August PM, Matté C, Wyse ATS, Wajner M, Leipnitz G (2017) Bezafibrate prevents mitochondrial dysfunction, antioxidant system disturbance, glial reactivity and neuronal damage induced by sulfite administration in striatum of rats: implications for a possible therapeutic strategy for sulfite oxidase deficiency. Biochim Biophys Acta 1863(9):2135–2148. https://doi.org/10.1016/j.bbadis.2017.05.019
Haliloglu G, Jobard F, Oguz K, Anlar B, Akalan N, Coskun T, Sass J, Fischer J, Topcu M (2008) L-2-hydroxyglutaric aciduria and brain tumors in children with mutations in the L2HGDH gene: neuroimaging findings. Neuropediatrics 39(02):119–122. https://doi.org/10.1055/s-2008-1081217
Halliwell BGJ (2015) Cellular responses to oxidative stress: adaptation, damage, repair, senescence and death. In: Free radicals in biology and medicine. Oxford University Press Inc, Oxford, pp 199–283. https://doi.org/10.1093/acprof:oso/9780198717478.003.0005
Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL (1993) Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis 16(4):648–669. https://doi.org/10.1007/BF00711898
Jellouli NK et al (2014) Founder effect confirmation of c.241A>G mutation in the L2HGDH gene and characterization of oxidative stress parameters in six Tunisian families with L-2-hydroxyglutaric aciduria. J Hum Genet 59(4):216–222. https://doi.org/10.1038/jhg.2014.4
Jovic NJ, Kosac A, Koprivsek K (2014) L-2-Hydroxyglutaric aciduria: a case report. Srp Arh Celok Lek 142:337–341
Junqueira D, Brusque AM, Porciúncula LO, Rotta LN, CAJ R, MES F, CSD F, CMD W, ATS W, Souza DO, Wajner M (2003) Effects of L-2-hydroxyglutaric acid on various parameters of the glutamatergic system in cerebral cortex of rats. Metab Brain Dis 18(3):233–243. https://doi.org/10.1023/A:1025559200816
Koeller DM, Woontner M, Crnic LS, Kleinschmidt-DeMasters B, Stephens J, Hunt EL, Goodman SI (2002) Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I. Hum Mol Genet 11(4):347–357. https://doi.org/10.1093/hmg/11.4.347
Koeller DM, Sauer S, Wajner M, de Mello CF, Goodman SI, Woontner M, Mühlhausen C, Okun JG, Kölker S (2004) Animal models for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27(6):813–818. https://doi.org/10.1023/B:BOLI.0000045763.52907.5e
Latini A, Scussiato K, Borba Rosa R, Leipnitz G, Llesuy S, Belló-Klein A, Dutra-Filho CS, Wajner M (2003) Induction of oxidative stress by L-2-hydroxyglutaric acid in rat brain. J Neurosci Res 74(1):103–110. https://doi.org/10.1002/jnr.10735
LeBel CP, Ischiropoulos H, Bondy SC (1992) Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 5(2):227–231. https://doi.org/10.1021/tx00026a012
Leong SF, Clark JB (1984) Regional development of glutamate dehydrogenase in the rat brain. J Neurochem 43(1):106–111. https://doi.org/10.1111/j.1471-4159.1984.tb06684.x
Levine RL, Williams JA, Stadtman ER, Shacter E (1994) Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233:346–357
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–275
Mannervik B, Guthenberg C (1981) Glutathione transferase (human placenta). Methods Enzymol 77:231–235. https://doi.org/10.1016/S0076-6879(81)77030-7
Marcel C, Mallaret M, Lagha-Boukbiza O, Kremer S, Echaniz-Laguna A, Tranchant C (2012) L-2-hydroxyglutaric aciduria diagnosed in a young adult with progressive cerebellar ataxia and facial dyskinesia. Rev Neurol 168(2):187–191. https://doi.org/10.1016/j.neurol.2011.06.002
Marklund SL (1985) Product of extracellular-superoxide dismutase catalysis. FEBS Lett 184(2):237–239. https://doi.org/10.1016/0014-5793(85)80613-X
Moroni I, Bugiani M, D’Incerti L, Maccagnano C, Rimoldi M, Bissola L, Pollo B, Finocchiaro G, Uziel G (2004) L-2-hydroxyglutaric aciduria and brain malignant tumors: a predisposing condition? Neurology 62(10):1882–1884. https://doi.org/10.1212/01.WNL.0000125335.21381.87
Navarro-Gonzalvez JA, Garcia-Benayas C, Arenas J (1998) Semiautomated measurement of nitrate in biological fluids. Clin Chem 44:679–681
Niizuma K, Endo H, Chan PH (2009) Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J Neurochem 109(Suppl 1):133–138. https://doi.org/10.1111/j.1471-4159.2009.05897.x
Olivera-Bravo S, Fernandez A, Sarlabos MN, Rosillo JC, Casanova G, Jimenez M, Barbeito L (2011) Neonatal astrocyte damage is sufficient to trigger progressive striatal degeneration in a rat model of glutaric acidemia-I. PLoS One 6(6):e20831. https://doi.org/10.1371/journal.pone.0020831
Olivera-Bravo S, Isasi E, Fernández A, Rosillo JC, Jiménez M, Casanova G, Sarlabós MN, Barbeito L (2014) White matter injury induced by perinatal exposure to glutaric acid. Neurotox Res 25(4):381–391. https://doi.org/10.1007/s12640-013-9445-9
Olivier P, Fontaine RH, Loron G, van Steenwinckel J, Biran V, Massonneau V, Kaindl A, Dalous J, Charriaut-Marlangue C, Aigrot MS, Pansiot J, Verney C, Gressens P, Baud O (2009) Melatonin promotes oligodendroglial maturation of injured white matter in neonatal rats. PLoS One 4(9):e7128. https://doi.org/10.1371/journal.pone.0007128
Patay Z, Mills JC, Lobel U, Lambert A, Sablauer A, Ellison DW (2012) Cerebral neoplasms in L-2 hydroxyglutaric aciduria: 3 new cases and meta-analysis of literature data. AJNR Am J Neuroradiol 33:940–943. https://doi.org/10.3174/ajnr.A2869
Reiter RJ, Tan DX, Rosales-Corral S, Manchester LC (2013) The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives. Min Rev Med Chem 13(3):373–384
Requejo R, Chouchani ET, Hurd TR, Menger KE, Hampton MB, Murphy MP (2010) Measuring mitochondrial protein thiol redox state. Methods Enzymol 474:123–147. https://doi.org/10.1016/S0076-6879(10)74008-8
Reznick AZ, Packer L (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233:357–363
Rodrigues DGB, de Moura Coelho D, Sitta Â, CED J, Hauschild T, Manfredini V, Bakkali A, Struys EA, Jakobs C, Wajner M, Vargas CR (2017) Experimental evidence of oxidative stress in patients with l-2-hydroxyglutaric aciduria and that l-carnitine attenuates in vitro DNA damage caused by d-2-hydroxyglutaric and l-2-hydroxyglutaric acids. Toxicol in Vitro 42:47–53. https://doi.org/10.1016/j.tiv.2017.04.006
Rzem R, Van Schaftingen E, Veiga-da-Cunha M (2006) The gene mutated in l-2-hydroxyglutaric aciduria encodes l-2-hydroxyglutarate dehydrogenase. Biochimie 88(1):113–116. https://doi.org/10.1016/j.biochi.2005.06.005
Sauer SW, Okun JG, Fricker G, Mahringer A, Müller I, Crnic LR, Mühlhausen C, Hoffmann GF, Hörster F, Goodman SI, Harding CO, Koeller DM, Kölker S (2006) Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. J Neurochem 97(3):899–910. https://doi.org/10.1111/j.1471-4159.2006.03813.x
Sauer SW, Opp S, Mahringer A, Kamiński MM, Thiel C, Okun JG, Fricker G, Morath MA, Kölker S (2010) Glutaric aciduria type I and methylmalonic aciduria: simulation of cerebral import and export of accumulating neurotoxic dicarboxylic acids in in vitro models of the blood-brain barrier and the choroid plexus. Biochim Biophys Acta 1802(6):552–560. https://doi.org/10.1016/j.bbadis.2010.03.003
Saxena G, Bharti S, Kamat PK, Sharma S, Nath C (2010) Melatonin alleviates memory deficits and neuronal degeneration induced by intracerebroventricular administration of streptozotocin in rats. Pharmacol Biochem Behav 94(3):397–403. https://doi.org/10.1016/j.pbb.2009.09.022
Seminotti B, Amaral AU, Ribeiro RT, MDN R, Colín-González AL, Leipnitz G, Santamaría A, Wajner M (2016) Oxidative stress, disrupted energy metabolism, and altered signaling pathways in glutaryl-CoA dehydrogenase knockout mice: potential implications of quinolinic acid toxicity in the neuropathology of glutaric acidemia type I. Mol Neurobiol 53(9):6459–6475. https://doi.org/10.1007/s12035-015-9548-9
Steenweg ME, Salomons GS, Yapici Z, Uziel G, Scalais E, Zafeiriou DI, Ruiz-Falco ML, Mejaški-Bošnjak V, Augoustides-Savvopoulou P, Wajner M, Walter J, Verhoeven-Duif NM, Struys EA, Jakobs C, van der Knaap MS (2009) L-2-Hydroxyglutaric aciduria: pattern of MR imaging abnormalities in 56 patients. Radiology 251(3):856–865. https://doi.org/10.1148/radiol.2513080647
Steenweg ME, Jakobs C, Errami A, van Dooren SJM, Adeva Bartolomé MT, Aerssens P, Augoustides-Savvapoulou P, Baric I, Baumann M, Bonafé L, Chabrol B, JTR C, Clayton P, Coker M, Cooper S, Falik-Zaccai T, Gorman M, Hahn A, Hasanoglu A, King MD, de Klerk HBC, Korman SH, Lee C, Meldgaard Lund A, Mejaški-Bošnjak V, Pascual-Castroviejo I, Raadhyaksha A, Rootwelt T, Roubertie A, Ruiz-Falco ML, Scalais E, Schimmel U, Seijo-Martinez M, Suri M, Sykut-Cegielska J, Trefz FK, Uziel G, Valayannopoulos V, Vianey-Saban C, Vlaho S, Vodopiutz J, Wajner M, Walter J, Walter-Derbort C, Yapici Z, Zafeiriou DI, Spreeuwenberg MD, Celli J, den Dunnen JT, van der Knaap MS, Salomons GS (2010) An overview of L-2-hydroxyglutarate dehydrogenase gene (L2HGDH) variants: a genotype-phenotype study. Hum Mutat 31(4):380–390. https://doi.org/10.1002/humu.21197
Topcu M et al (2004) L-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1. Hum Mol Genet 13(22):2803–2811. https://doi.org/10.1093/hmg/ddh300
Topcu M et al (2005) L-2-hydroxyglutaric aciduria: a report of 29 patients. Turk J Pediatr 47(1):1–7
Wajner M, Goodman SI (2011) Disruption of mitochondrial homeostasis in organic acidurias: insights from human and animal studies. J Bioenerg Biomembr 43(1):31–38. https://doi.org/10.1007/s10863-011-9324-0
Wendel A (1981) Glutathione peroxidase. Methods Enzymol 77:325–333. https://doi.org/10.1016/S0076-6879(81)77046-0
Wilt SG, Dugger NV, Hitt ND, Hoffman PM (2000) Evidence for oxidative damage in a murine leukemia virus-induced neurodegeneration. J Neurosci Res 62(3):440–450. https://doi.org/10.1002/1097-4547(20001101)62:3<440::AID-JNR14>3.0.CO;2-M
Yagi K (1998) Simple procedure for specific assay of lipid hydroperoxides in serum or plasma. Methods Mol Biol 108:107–110. https://doi.org/10.1385/0-89603-472-0:107
Yilmaz K (2009) Riboflavin treatment in a case with l-2-hydroxyglutaric aciduria. Eur J Paediatr Neurol 13(1):57–60. https://doi.org/10.1016/j.ejpn.2008.01.003
ᅟ
Funding
This work was supported by grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico #404883/2013-3, Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul #2266-2551/14-2, Pró-Reitoria de Pesquisa/Universidade Federal do Rio Grande do Sul #PIBIC 27613, FIPE/HCPA, and Financiadora de Estudos e Projetos/Rede Instituto Brasileiro de Neurociência #01.06.0842-00.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Approval
The experimental protocol was approved by the Ethics Committee for Animal Research of the UFRGS, Porto Alegre, Brazil, and followed the “National Institutes of Health Guide for the Care and Use of Laboratory Animals” (NIH Publications No. 85–23, revised 2011).
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Ribeiro, R.T., Zanatta, Â., Amaral, A.U. et al. Experimental Evidence that In Vivo Intracerebral Administration of L-2-Hydroxyglutaric Acid to Neonatal Rats Provokes Disruption of Redox Status and Histopathological Abnormalities in the Brain. Neurotox Res 33, 681–692 (2018). https://doi.org/10.1007/s12640-018-9874-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-018-9874-6